Learn More
BACKGROUND Most of the studies evaluating rash in HIV-positive patients have focused on nonnucleoside reverse transcriptase inhibitors (NNRTI), particularly nevirapine, and little is known about the(More)
We read the article by Msango et al. [1] with great interest and pleasure. The article addresses the prevalence of renal dysfunction among antiretroviral therapy (ART)-naı̈ve HIV-infected patients(More)